2023
Entrant
Category
Client's Name
Country / Region
About The Entry
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Entrant
Atrium Health
Category
Experiential & Immersive - Community
Country / Region
United States
Entrant
The Pridham Group
Category
Website - Health
Country / Region
Canada
Entrant
Digital Brew
Category
Video - Motion Graphics
Country / Region
United States
Entrant
Preston Spire
Category
Video - Political
Country / Region
United States